Till startsida
Till innehåll Läs mer om hur kakor används på gu.se


Globala Aktörer

Global Antibiotic Research and Development (GARD) Partnership Incubation (formerly known as WHO - DNDi Collaboration) promotes innovation and responsible use and access to new antibiotics.

Foundation for Innovative New Diagnostics (FIND) is an international non-profit organization that enables the development and delivery of much-needed diagnostic tests for poverty-related diseases

Community for Open Antimicrobial Drug Discovery (CO-ADD) is a not-for-profit initiative launched in March 2015 reaching out to chemists in academia and research organisations who have compounds ‘sitting on shelves’ that were not designed as antibiotics and would not otherwise be screened for antimicrobial activity.


Europeiska Regionen

Joint Programming Initiative on AMR (JPIAMR), coordinates national funding and supports collaborative action to fill knowledge gaps in this field.

The Innovative Medicines Initiative (IMI) is working to improve health by speeding up the development of, and patient access to, innovative medicines, particularly in areas where there is an unmet medical or social need.

European Academies Science Advisory Council (EASAC) is formed by the national science academies of the EU Member States to enable them to collaborate with each other in providing independent science advice to European policy-makers.

BEAM Alliance - Biotechs of Europe Innovating in Antimicrobial Resistance are a group of Biopharmaceutical companies from Europe innovating in Anti-Microbial resistance research.

InnovFin Infectious Diseases aims to stimulate investments in the development of innovative vaccines, drugs, medical and diagnostic devices or novel research infrastructures for infectious diseases.


Syd-Öst Asiatiska Regionen

Asia Pacific Foundation for Infectious Diseases (APFID) was founded to improve the global health through Asian initiatives by strengthening and coordinating national and international research-related activities on infectious diseases and antimicrobial resistance.

Sidansvarig: Kristian Kvint|Sidan uppdaterades: 2016-04-21

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?